Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G I Scott

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Drugs|October 18, 2015
Optimizing Methotrexate Treatment in Rheumatoid Arthritis: The Case for Subcutaneous Methotrexate Prior to BiologicsPoonam Sharma, David G I Scott
Rheumatology (Oxford, England)|November 19, 2020
Toxoplasmosis and treatment for rheumatic diseases: what are the risks?Barbara M Lund, David G I Scott
Rheumatology (Oxford, England)|August 28, 2012
ANCA vasculitis: to lump or split? Why we should study MPA and GPA separatelyRichard A Watts, David G I Scott
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Epidemiology of the vasculitidesRichard A Watts, David G I Scott
Best Practice & Research. Clinical Rheumatology|June 11, 2009
Recent developments in the classification and assessment of vasculitisRichard A Watts, David G I Scott
Clinical and Experimental Nephrology|July 12, 2013
Epidemiology and clinical features of systemic vasculitisDavid G I Scott, Richard A Watts
Rheumatology (Oxford, England)|December 15, 2010
50th volume--60 years. A golden yearDavid G I Scott, Robert J Moots
Lancet (London, England)|May 4, 2005
Increased risk of cardiovascular events with coxibs and NSAIDsDavid G I Scott, Richard A Watts
Current Opinion in Rheumatology|December 24, 2002
Epidemiology of the vasculitidesRichard A Watts, David G I Scott
Best Practice & Research. Clinical Rheumatology|December 15, 2016
Vasculitis and inflammatory arthritisRichard A Watts, David G I Scott
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Drugs|October 18, 2015
Optimizing Methotrexate Treatment in Rheumatoid Arthritis: The Case for Subcutaneous Methotrexate Prior to BiologicsPoonam Sharma, David G I Scott
Rheumatology (Oxford, England)|November 19, 2020
Toxoplasmosis and treatment for rheumatic diseases: what are the risks?Barbara M Lund, David G I Scott
Rheumatology (Oxford, England)|August 28, 2012
ANCA vasculitis: to lump or split? Why we should study MPA and GPA separatelyRichard A Watts, David G I Scott
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Epidemiology of the vasculitidesRichard A Watts, David G I Scott
Best Practice & Research. Clinical Rheumatology|June 11, 2009
Recent developments in the classification and assessment of vasculitisRichard A Watts, David G I Scott
Clinical and Experimental Nephrology|July 12, 2013
Epidemiology and clinical features of systemic vasculitisDavid G I Scott, Richard A Watts
Rheumatology (Oxford, England)|December 15, 2010
50th volume--60 years. A golden yearDavid G I Scott, Robert J Moots
Lancet (London, England)|May 4, 2005
Increased risk of cardiovascular events with coxibs and NSAIDsDavid G I Scott, Richard A Watts
Current Opinion in Rheumatology|December 24, 2002
Epidemiology of the vasculitidesRichard A Watts, David G I Scott
Best Practice & Research. Clinical Rheumatology|December 15, 2016
Vasculitis and inflammatory arthritisRichard A Watts, David G I Scott
Pageof 5